Hsbc Holdings PLC Rubius Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$8.02 - $32.01 $332,485 - $1.33 Million	-41,457 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$4.23 - $8.73 $98,389 - $203,059	23,260 Added 127.82%	41,457 $314,000
Q3 2020 Nov 12, 2020	BUY	$4.65 - $6.25 $17,549 - $23,587	3,774 Added 26.17%	18,197 $92,000
Q2 2020 Aug 14, 2020	BUY	$4.01 - $6.88 $57,836 - $99,230	14,423 New	14,423 $86,000
Q4 2019 Feb 14, 2020	SELL	$7.23 - $14.12 $102,268 - $199,727	-14,145 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$7.85 - $15.75 $111,038 - $222,783	14,145 New	14,145 $111,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.